← SynDRA
NVP.BVU972
SynDRA canonical compound SYN1970574 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MET |
| Mechanism of action | MET inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- NVP BVU972
- NVP-BVU-972
- 6-[[6-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline
- 6-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl)methyl)quinoline
- CHEMBL1738731
- MPC3100
- 6-{[6-(1-Methyl-1h-Pyrazol-4-Yl)imidazo[1,2-B]pyridazin-3-Yl]methyl}quinoline
- BVU972
- 3qti
- NVPBVU972
- MLS006010964
- SCHEMBL1659100
- BVU-972
- DTXSID40657890
- HMS3656L04
- BCP03600
- EX-A2116
- BDBM50146169
- s2761
- ZINC66166253
- AKOS026750599
- BCP9000466
- CCG-267923
- CS-0967
- NCGC00346689-01
- NCGC00346689-02
- NCGC00346689-06
- AC-35941
- AS-56284
- HY-15456
- SMR004702768
- BCP0726000188
- SW219959-1
- C71592
- Q27454048
- 6-[6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazin-3-ylmethyl]-quinoline
Look up NVP.BVU972 in the interactive SynDRA portal →